| | |
| | |
| Clinical data | |
|---|---|
| Other names | NsBT; NSBT |
| Routes of administration | Oral [1] [2] |
| Drug class | Psychoactive drug [1] [2] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | "Short" [1] |
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C14H20N2 |
| Molar mass | 216.328 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
N-sec-Butyltryptamine (NsBT) is a psychoactive drug of the tryptamine family related to psychedelics like dimethyltryptamine (DMT). [1] [2]
NsBT was briefly described by Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved). [1] According to Shulgin, NsBT is active at a dose of 25 to 75 mg orally and has a short-lived duration. [1] [2] Its effects included a generalized and somewhat diffuse intoxication, intellectual excitement, modest sensory enhancements, and "a lot of erotic horniness". [1] However, no "plus-three" ratings occurred on the Shulgin Rating Scale. [1]
Shulgin has said that along with N-tert-butyltryptamine (NtBT), it is one of only two N-mono-substituted tryptamines with known psychoactivity. [1] He also said that N-mono-substituted tryptamines might be GHB-like intoxicants devoid of psychedelic effects. [1] However, N-methyltryptamine (NMT) has been reported to produce psychedelic effects. [1] [3] [4]
Analogues of NsBT include N-methyltryptamine (NMT), N-ethyltryptamine (NET), N-isopropyltryptamine (NiPT), N-benzyltryptamine (NBnT), and N-methyl-N-sec-butyltryptamine (MsBT), among others. [1]
{{cite conference}}: CS1 maint: bot: original URL status unknown (link)